size that lysoPCs induce Hck-dependent activation of protein kinase C (PKC), resulting in phosphorylation and membrane translocation of 47 kDa phagocyte oxidase protein (p47 phox ). PMNs, human or murine, were primed with lysoPCs and were smeared onto slides and examined by digital microscopy or separated into subcellular fractions or whole-cell lysates. Proteins were immunoprecipitated or separated by polyacrylamide gel electrophoresis and immunoblotted for proteins of interest. Wild-type (WT) and PKCg knockout (KO) mice were used in a 2-event model of TRALI. LysoPCs induced Hck coprecipitation with PKCd and PKCg and the PKCd:PKCg complex also had a fluorescence resonance energy transfer (FRET) + interaction with lipid rafts and WiskottAldrich syndrome protein family verprolin-homologous protein 2 (WAVE2). PKCg then coprecipitated with p47 phox . Immunoblotting, immunoprecipitation (IP), specific inhibitors, intracellular depletion of PKC isoforms, and PMNs from PKCg KO mice demonstrated that Hck elicited activation/Tyr phosphorylation (Tyr311 and Tyr525) of PKCd, which became Thr phosphorylated (Thr507). Activated PKCd then caused activation of PKCg, both by Tyr phosphorylation (Τyr514) and Ser phosphorylation, which induced phosphorylation and membrane translocation of p47
phox . In PKCg KO PMNs, lysoPCs induced Hck translocation but did not evidence a FRET + interaction between PKCd and PKCg nor prime
PMNs. In WT mice, lysoPCs served as the second event in a 2-event in vivo model of TRALI but did not induce TRALI in PKCg KO mice. We conclude that lysoPCs prime
Introduction
PMNs are critical in host defense against microbial invaders and exert their major microbicidal function in the tissues [1] . PMNs emigrate to the tissues in an orderly fashion, including selectinmediated loose attachment or rolling, b 2 -integrin-mediated firm adhesion, and diapedesis through the endothelial layer, which involves platelet endothelial adhesion molecule [2] [3] [4] [5] . Priming is an endogenous part of PMN function and changes the PMN phenotype from nonadherent to adherent and also augments release of the components of the microbicidal arsenal, both oxidative and nonoxidative, to a subsequent stimulus [6] [7] [8] .
Priming agents also cause phosphorylation and translocation of specific cytosolic oxidase components: p47 phox , p67 phox , p40 phox , Rac-2, p29 phox (perioxiredoxin-6), to the membrane; however, they do not cause oxidase assembly/activation [7, [9] [10] [11] [12] [13] . Lastly, priming agents render the PMN functionally hyper-reactive, such that stimuli that do not induce activation of the NADPH oxidase and release of the nonoxidative components of the microbicidal arsenal in quiescent cells readily cause activation of primed cells [6, 14, 15] . In short, primed PMNs may be activated by a priming agent [14, 15] . LysoPCs are effective priming agents and are ligands for the G2A receptor, present on the PMN membrane [13, 16] . LysoPCs are mostly found as a mixture of compounds in plasma and have been implicated in TRALI, which is PMN-mediated with a 2-event pathogenesis [13, [17] [18] [19] . LysoPCs accumulate during the storage of cellular blood components, platelet concentrates, and unmodified RBC units and can cause the second event in TRALI, which is the activation of sequestered PMNs in the pulmonary microvasculature, resulting in endothelial cell damage, capillary leak, and ALI [20] [21] [22] [23] . In addition, infusion of lysoPCs into mice with bacterial pneumonia increases survival and aids in the eradication of the bacterial pathogens [24] .
LysoPCs induce rapid priming of neutrophils and cause Ser phosphorylation of p47 phox and its translocation from the cytosol to the PMN membrane [13, 16] . Moreover, lysoPCs induce ligation of the G2A receptor and cause coprecipitation of G2A with clathrin and b-arrestin-1 [16] . Simultaneously lysoPCs elicit release of 2 separate G-protein subunits, G ai and G aq11 , which cause a rapid increase in cytosolic Ca 2+ [16] . The G bg subunits, which are released from G ai and G aq11 , cause activation of the Src family kinase Hck, although little is known with regard to the intracellular events that result in lysoPC-induced Ser phosphorylation of and translocation of p47 phox [16] . We hypothesize that lysoPCs induce Hck-dependent activation of PKC, resulting in phosphorylation of p47 phox and translocation to the PMN membrane.
MATERIALS AND METHODS

Materials
All chemicals, unless otherwise indicated, were purchased from Sigma-Aldrich (St. Louis, MO, USA). All solutions were made from sterile water, USP, purchased along with sterile 0.9% saline, USP, from Baxter Healthcare (Deerfield, NY, USA), with buffers that are pyrogen free for human intravenous administration [13, 25] 
LysoPC preparation
LysoPCs were solubilized in 1.25%, essentially fatty acid-and globulin-free human albumin and consisted of 1-o-palmitoyl:0.8 mM, 1-o-oleoyl:0.3 mM, 1-ostearoyl:0.3 mM, and 1-o-hexadecyl (C 16 ) lysoPAF:0.003 mM stock, as published [13] .
PMN isolation
PMNs were isolated from whole blood drawn from healthy donors under a protocol approved by the Colorado Multiple Institutional Review Board at the University of Colorado Denver and used standard techniques: Dextran sedimentation, Ficoll-Paque gradient centrifugation, and hypotonic lysis of contaminating RBCs [20] . Cells were resuspended (2.5 3 10 7 cells/ml) in
Krebs-Ringer phosphate with 2% dextrose, pH 7.35.
Real-time PCR for PKCg
Total RNA was isolated from PMNs from 2 healthy donors using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) and was quantified spectrophotometrically and compared with total RNA from cultured human SAECs (Lonza, Walkersville, MD, USA). In brief, 1 mg total RNA was used to prepare cDNA using the qScript cDNA SuperMix (Quantabio, Beverly, MA, USA). Real-time PCR was performed on an iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA). All primer-probe gene-expression assays for real-time analyses were purchased from Thermo Fisher Scientific (PKCg Assay ID Hs00177010_m1, GAPDH Assay ID Hs99999905_m1). Total cDNA (2 ml) was used to assay PKCg transcripts, and 1 ml 1:10 dilution of the cDNA was to assay for GAPDH as a housekeeping control. All products were run on a 1.5% agarose gel for further validation.
PMN subcellular fractions
Isolated PMNs (1 3 10 8 cells/ml) were stimulated with 4.5 or 14.5 mM lysoPCs for 0.5-5 min. The reaction was stopped with an equal volume of relaxation buffer (3.5 mM MgCl 2 , 100 mM KCl, 3 mM NaCl, and 10 mM PIPES, pH 7.4) and then sonicated 3 times for 30 s. The lysate was centrifuged to get the postnuclear supernatant, which was loaded onto a 15-60% sucrose gradient. The gradient was centrifuged at 100,000 g for 60 min at 4°C. The cytosol, membrane, and granular fractions were removed, protein concentration determined by BCA, and the proteins separated by 10% SDS-PAGE with each fraction from the same number of cellular equivalents [26] . The proteins were transferred to nitrocellulose membranes, blocked in BSA, and immunoblotted [26] . The subcellular fractions were immunoprecipitated for the proteins of interest [26] . To control for possible nonspecificity of the antibodies used, IPs were completed for PKCg and PKCd and the proteins separated by SDS-PAGE, immunoblotted, and probed with multiple antibodies to PKCa, -b I , -b II , -g, and -d. The PKCg IP did not demonstrate immunoreactivity with any of the other antibodies to PKC isoenzymes, and identical experiments were performed for IPs of PKCd, which yielded identical results (Supplemental Fig.  1 ). When IPs were performed, they were reversed so that the protein that was probed in the IP was then immunoprecipitated, and the other protein that colocalized was probed in this IP.
PKC activity assay in PMN subcellular fractions PKC activity kits were purchased from EMD Millipore (Billerica, MA, USA). These assays were performed on subcellular fractions in triplicate, per the (continued from previous page) p47 phox = 47 kDa phagocyte oxidase protein, PAF = platelet-activating factor, pHck = phosphorylated Hck, PKC = protein kinase C, PMN = polymorphonuclear leukocyte/neutrophil, PP2 = pyrazolpyrimidine, pPKC = phosphorylated protein kinase C, SAEC = small airway epithelial cell, TRALI = transfusion-related acute lung injury, USP = U.S. Pharmacopeial Convention, WAVE2 = WiskottAldrich syndrome protein family verprolin-homologous protein 2, WGA = wheat germ agglutinin, WT = wild-type mouse manufacturer's instructions. These assays use 96-well plates coated with a PKC pseudosubstrate. The phosphorylated pseudosubstrate is recognized by a biotinylated antibody. An HRP-labeled streptavidin detects the biotin and is quantified at 492 nm.
Digital microscopy
Isolated PMNs were incubated with albumin or lysoPCs (1.45-14.5 mM) for 1-10 min, fixed with 4% paraformaldehyde, smeared onto slides, washed, porated, and incubated with a primary antibody or a primary-labeled antibody, WGA, and bis-benzimide [26] . In cases where the unlabeled primary antibody was used, slides were also incubated with a labeled secondary [27] . Lipid rafts were identified by labeling with Alexa 555 CTB [28] .
The PMNs were imaged at 1003 (Zeiss NA1.4, working depth 2.2 mm), and the data from 3 epifluorescence channels were digitized on a cooled CCD camera at 1280 3 1024 pixels with 12-bit fidelity [26] . To ensure that the fluorescent intensity data were not saturated, the cell body and the cell membrane were selected by threshold masking on the WGA intensity and by subselection of the highest intensity edge, respectively. The individual cells were counted (submasking), each by total area and membrane area [26] . In each region, area (cellular footprint), mean intensities, and total intensities were calculated for each channel. The data for the 2 regions of interest (7 3 2) in each cell (30 PMNs/group) were loaded onto StatView software (4.5; SAS Institute, Cary, NC, USA) and analyzed by ANOVA. Translocation was derived from the total immunoreactivity intensity in the membrane relative to the total cellular intensity. Selection of the regions of interest with the intensity of WGA staining for sialo-membranes (FITC channel) removed bias in assessing the integrated intensity contained in those regions (Cy-3) [26] .
PMN isolation from mice
All procedures were approved by the Institutional Animal Care and Use Committee at the University of Colorado Denver. WT and PKCg KO mice were anesthetized with sodium pentobarbital (60 mg/kg) and blood removed via cardiac puncture and loaded onto Histopaque gradient for separation at 700 g, 20 min. Hypotonic lysis removed RBCs, and the PMNs were resuspended at 2.5 3 10 7 cells/ml [29] .
In vitro activation of PKC
Isolated human PMNs warmed to 37°C for 3 min; an equal volume of relaxation buffer added; the PMNs sonicated in 3, 30 s pulses, centrifuged at 2500 g for 10 min at 4°C; and the supernatant saved. After a BCA analysis was done, 25 mg protein was immunoprecipitated for PKCg, PKCd, or Hck overnight at 4°C. After incubation with protein A/G beads to pull down the protein, the beads were pelleted, and the immunodepleted supernatant was removed. Fifty percent (v:v) of the supernatant was used for activation assays with recombinant proteins, with active recombinant proteins added to the immunodepleted supernatant: 240 (PKCg), 302 (PKCd), or 196 mU (Hck), and brought to a final volume with 13 kinase reaction buffer (Thermo Fisher Scientific). After addition of the active protein, the reaction was stopped with 43 SDS digestion buffer. Proteins were separated by SDS-PAGE and immunoblotted with phospho-antibodies.
A murine model of ALI
An in vivo murine model of ALI, identical to our rat model, was completed [19] . WT and PKCg KO mice were weighed, injected intraperitoneally with NS or LPS (Salmonella enteritides, 2 mg/kg), and incubated (2 h). Mice were anesthetized, the tail vein cannulated, and blood withdrawn, 10% of total blood volume [body weight (kg) 3 70] . Mice were infused with NS or 4.5 mM lysoPCs (4 ml/h), followed by EBD (30 mg/kg), and incubated (6 h). Mice were reanesthetized, blood was drawn via cardiac puncture, and the mice were euthanized, followed by a BAL [19] . The blood and BALF were centrifuged and supernatants stored at 280°C. ALI was determined as the percentage of EBD leak from the plasma into BALF [19] .
Statistical analysis
Data are presented as the means 6 SEM and were analyzed with independent or repeated-measures ANOVA with a post hoc Bonferroni or Newman-Keuls test for multiple comparisons, based on the equality of variance.
RESULTS
LysoPCs cause activation of PKC and translocation of PKCg and PKCd
LysoPCs rapidly caused an increase in general PKC activity in the PMN membrane at concentrations of 4.5 and 14.5 mM, with the higher concentration resulting in increased PKC activity in both the cytosolic and granule fractions (Fig. 1A) . The translocation of specific PKC isozymes was investigated, using antibodies to both cPKC (Ca 2+ dependent)-PKCa, PKCb I , PKCb II , and PKCg-and a nPKC (Ca 2+ independent)-PKCd (Fig. 1B) . To ensure specificity of the observed immunoreactivity, divergent antibodies were used from different vendors, and positive controls were used for each PKC isozyme. The data demonstrated identical results for the different antibodies to each PKC isozyme, and the positive controls were only recognized by antibodies specific for this protein (data not shown). As a further control, when the recognized polypeptide sequence was available, it was added with the primary antibody to ensure that the immunoreactivity was specific for each PKC (data not shown). In albumin-treated controls, PKCa is mainly in the cytosol, with modest immunoreactivity present in the membrane and trace amounts in the granules (Fig. 1B) . The patterns for lysoPCs were similar to controls; however, PMA induced increased PKCa in the membrane with relatively less in the cytosol, indicative of membrane translocation with trace amounts in the granule fraction. The same trend is seen with PKCb I and PKCb II , such that PMA caused membrane translocation of both of these PKC isozymes, whereas albumin and lysoPCs did not. In contrast, lysoPCs caused translocation of both PKCg and PKCd to the membrane with less immunoreactivity in the cytosol versus both albumin and PMA (Fig. 1B, black arrows) . In short, lysoPCs (4.5 mM) caused membrane translocation of PKCg and PKCd (Fig. 1B) . PKCg translocation was confirmed by digital microscopy, which demonstrated lysoPC-mediated colocalization with actin at the PMN membrane (Fig. 1C) .
As human PMNs have not been reported to contain PKCg, total RNA was isolated from human PMNs. An 89 bp mRNA transcript specific for PKCg was present in PMNs from 2 healthy donors and was at the same migration as the PKCg mRNA transcript from SAECs, the positive control (Fig. 1D) . GAPDH was used as a loading control (Fig. 1D) .
Activation of PKCg and the association between PKCd and PKCg
As PKCg requires Thr phosphorylation and Ser phosphorylation for activation, the membranes of lysoPCs primed with 4.5 mM lysoPCs for 1-5 min were immunoprecipitated for PKCg and immunoblotted for phosphoserine or Thr pPKCg (Tyr514; Fig.  2A and B) with a bar graph of the densitometry of the bands from 3 gels depicted below [30, 31] . LysoPCs vs. albumin-treated controls induced translocation of pPKCg to the membrane at 1 min (Fig. 2B) and Ser-pPKCg to the membrane at 1 and 3 min, with a bar graph of the densitometry included below ( Fig. 2A) .
As compared with albumin-treated controls, lysoPCs (4.5 mM) induced coprecipitation of PKCg with PKCd at the membrane (Fig. 3Ai) , with a bar graph of the densitometry from 3 different experiments included below. lysoPCs also induced the pPKCd to coprecipitate with PKCg at the membrane [both Tyr (Tyr311 and Tyr525; Fig. 3Aii and iii) and Thr (Thr514) pPKCd]; note the bar graphs of the densitometry below (Fig. 3Aiv) . Importantly, pPKCd (Tyr525) is the human equivalent of rodent Tyr pPKCd (Tyr523). The lysoPC-mediated interaction of pPKCd (Tyr525) with lipid rafts was confirmed by digital microscopy using fluorescently labeled CTB for imaging of lipid rafts (Fig. 3B ) [28] . Identical data demonstrated that pPKCg (Tyr514) also colocalized with lipid rafts, and IP of PKCd from lysoPC-primed PMNs demonstrated coprecipitation of PKCg (results not shown). Taken as a whole, both the IPs and digital microscopy demonstrated that lysoPCs caused translocation of pPKCd and pPKCg to the plasma membrane in a physical relationship with one another.
The dependence of PKCg on PKCd
To explore further the physical relationship of PKCd and PKCg, isolated PMNs were pretreated with 1 mM BAPTA-AM, or DMSO control to chelate intracellular Ca 2+ . Chelation of cytosolic Ca abrogated the FRET + interaction between PKCg and PKCd ( Fig. 4A) , inhibited lysoPC-induced translocation of PKCg to the membrane (Fig. 4Bi ), but only partially attenuated membrane translocation of PKCd (Fig. 4Bii) . When PMNs were pretreated with DMSO (vehicle); Gö6983, a cPKC inhibitor (50 nM); Rottlerin, a nonspecific PKC antagonist (10 mM) that may inhibit PKCd; or AEB071, a pan-PKC inhibitor that at 2 nM, will inhibit PKCd (2 nM) but not PKCg, both Rottlerin (10 mM) and AEB071 decreased the coprecipitation of PKCd with PKCg in the membrane, whereas Gö6983 had no effect ( Fig. 4Biii and iv) [32] [33] [34] . Rottlerin pretreatment (10 mM) also inhibited lysoPC priming of the fMLF-activated oxidase by 100 6 8% (P , 0.05, n = 5). Taken as a whole, the inhibitor data implicated PKCd in the activation of PKCg and lysoPC priming of PMNs. In addition, isolated PMNs were pretreated with other PKC inhibitors: staurosporine (25-50 nM), Bis I (50 nM), and Gö6976 (50 nM). In PMNs primed with lysoPCs and followed by fMLF activation, the PKC inhibitors significantly inhibited the oxidase response compared with DMSO controls (Fig. 4C ). These data reinforce that PKCd and PKCg activity is required for lysoPC priming.
Hck activates PKCd, which activates PKCg
LysoPCs, via the GPCR G2A, phosphorylate Hck, a Src family tyrosine kinase [16] . Digital microscopy of lysoPC-primed PMNs demonstrated that lysoPCs elicited a FRET + physical association of pPKCg with pHck (Tyr411) and pPKCd with pHck, and an overlay of these two FRETs demonstrated colocalization (Fig.  5A) . Therefore, lysoPCs elicited a complex containing all 3 kinases: pHck, pPKCd, and pPKCg. Pretreatment of PMNs with PP2, an Src tyrosine kinase inhibitor, inhibited pPKCg and pPKCd (Fig. 5Bi) . Hck was immunoprecipitated from PMNs primed with lysoPCs (0.5-5 m) and immunoblotted for PKCd, and the converse was also completed. LysoPCs induced coprecipitation of Hck with PKCd from 1 to 5 m (Fig. 5Ci) . PKCg and PKCd were also immunoprecipitated from PMNs and immunoblotted with WAVE2 and both PKCs coprecipitated with WAVE2 ( Fig. 5Ciii and iv) . Furthermore, pretreatment of PMNs with the tyrosine kinase inhibitor genistein inhibited lysoPC priming of the fMLF-activated respiratory burst by 78 6 7% (P , 0.05, n = 6 vs. the DMSO vehicle) [35] .
As lysoPC priming of PMNs results in the translocation and physical interaction of Hck, PKCd, and PKCg at the membrane, PMN cellular extracts were immunodepleted of the desired protein, an active recombinant kinase was added back, and the extracts were probed for activated kinases that were presumed to be downstream of the active recombinant kinases. Active recombinant Hck was added to PMN extracts "immunodepleted" of Hck, and this addition resulted in pPKCd at Tyr525 at 15 s (Fig. 6A ) with subsequent pPKCg (Thr514) at 60 s. In addition, when PKCd-immunodepleted PMN extracts were given active PKCd, there was an increase in pPKCg (Thr514), beginning at 30 s, with maximal pPKCg at 60 s, which persisted for 5 min (Fig. 6B) . However, when PKCgimmunodepleted PMNs were given active PKCg, there was no increase in pPKCd (Fig. 6C) . These data provide evidence that Hck phosphorylates PKCd, which in turn, phosphorylates PKCg.
PKCg KO mice
In isolated PMNs from both WT and PKCg KO mice, no discernible PKCg immunoreactivity was present in the KO mice compared with the WT, which was confirmed by Western blotting (Fig. 7Ai) and digital microscopy, in that both the PMNs from WT and PKCg KO mice took up WGA in their membranes, and only the PMNs from WT mice had PKCg immunoreactivity (Fig.  7Aii) . When the PMNs from WT and PKCg KO mice were treated for 1 min with lysoPCs, PKCg (red) was translocated to the membrane (WGA, green) in the WT mouse PMNs, yielding a yellow color that was not present in the PKCg KO mice (Fig.  7Aiii ). As seen with human PMNs, lysoPCs significantly primed the fMLF-activated respiratory burst in PMNs from WT mice (P , 0.05, n = 5; Fig. 7Bi) ; however, in the PKCg KO mice, lysoPCs did not prime the fMLF-activated respiratory burst, whereas PAF, the positive control, did (P , 0.05, n = 5; Fig. 7Bii ). These data suggested that PKCg is important in the lysoPC priming of the NADPH oxidase in murine PMNs. Furthermore, in the PMNs from both WT and PKCg KO mice, lysoPCs elicited pHck translocation to the membrane (Fig. 7Ci) . Moreover, in WT mouse PMNs, PKCg is present (red), which overshadows the PKCd (green), whereas in the PKCg KO PMNs, there is only the faint green color of PKCd (Fig. 7Cii, upper) . LysoPCs induced colocalization (yellow) of PKCg (red) and pPKCd (green; Fig.  7Cii, lower left) . No colocalization was visualized in the lysoPCstimulated PMNs from PKCg KO mice, which demonstrated only faint PKCd immunoreactivity (green; Fig. 7Cii , lower right).
p47 phox phosphorylation and translocation and PKCg activation
LysoPCs caused the translocation of p47 phox from the cytosol to the membrane at 5 min, and p47 phox was phosphorylated on serine (Fig. 8A) . These data were expanded by digital microscopy and demonstrated that lysoPCs, compared with albumin-treated PMNs, induced a FRET + interaction of p47 phox with phosphoserine at 5 min (Fig. 8Bi and ii, lower, blue panels), and the FRET between p47
phox and phosphoserine demonstrated a FRET + interaction at 5 min with lipid rafts, which are contiguous with the PMN membrane (Fig. 8B) [36, 37] . In addition, active, pPKCg coprecipitated with p47 phox at the PMN membrane at 5 min, providing evidence of direct pPKCg of p47 phox (Fig. 9A) . To investigate the relationship further among PKCd, PKCg, and p47
phox , a time course of the PKCd and PKCg interaction with p47 phox was completed and demonstrated that the FRET + interaction between PKCd and PKCg (green) was maximal at 1 min before the FRET + interaction between PKCg and p47 phox (red), which occurs at 5 min ( Fig. 9B ) with minimal interactions between PKCd and PKCg and PKCg and p47 phox in albumintreated controls (Fig. 9B) . Further confirmation of the PKCg: p47 phox relationship is illustrated in Fig. 9C , demonstrating that lysoPCs induced a FRET + interaction between and PKCg and p47 phox in the PMN membrane at 5 min, which is not present in control PMNs (Fig. 9C ). In addition, in the PMNs from WT mice, lysoPCs elicited a FRET + interaction between PKCd and p47 phox , which was not present in the albumin-treated controls nor in PMNs from the PKCg KO mice (Fig. 9D) . Importantly, there was obvious PKCd immunoreactivity in WT and PKCg KO animals and the lack of a FRET + interaction in the PMNs from PKCg KO mice confirms the need for PKCg for lysoPC-mediated interactions among PKCd, PKCg, and p47 phox (Fig. 9D ).
Lung injury in PKCg KO mice
As lysoPCs induce ALI as the second event in a 2-event in vivo model, an identical murine model was used consisting of WT and PKCg KO mice [19] . The rodents were injected intraperitoneally with NS or LPS (2 mg/kg), and the animals were incubated for 2 h and then infused via the tail vein with NS or lysoPCs (4.5 mM), followed by EBD [19] . WT mice that received LPS IP, followed by lysoPC infusion, developed significant EBD lung leak versus mice that were transfused with NS or received NS as the first event, regardless of the second (Fig. 10) . However, PKCg KO mice that received LPS, followed by the infusion of lysoPCs, did not evidence ALI (Fig. 10) .
DISCUSSION
LysoPCs at concentrations found in stored, cellular blood components cause activation of the Src family kinase Hck, which coprecipitates with PKCd and PKCg and the cytoskeletal protein (ii) In the PMNs from PKCg KO mice, fMLF also caused significant activation of the oxidase; however, lysoPCs did not prime and augment the fMLF-activated respiratory burst, but PAF did (*P , 0.05 vs. albumin-treated PMNs, #P , 0.05 vs. fMLF-activated PMNs, n = 5). (Ci) Isolated PMNs from WT and PKCg KO mice were treated with albumin or 4.5 mM lysoPCs for 1 min, demonstrating Hck immunoreactivity (red). Identical PMNs from WT and PKCg KO mice were treated with albumin (control) or lysoPC for 1 min, incubated with primary antibodies to PKCg (red) or pPKCd (green), and examined by digital microscopy (ii). There is PKCg immunoreactivity in the PMNs from WT mice, which masks the PKCd green immunoreactivity, and there is no PKCg immunoreactivity with some PKCd immunoreactivity (green) in the PMNs from the PKCg KO mice. LysoPCs induced pPKCd immunoreactivity (green) and colocalization of pPKCd and PKCg (yellow; lower left), but there is only pPKCd immunoreactivity in lysoPC-primed PMNs from PKCg KO mice (right). All figures are representative of 3 separate experiments. WAVE2. From time courses, intracellular neutralization of specific proteins, and the use of in vitro assays and multiple inhibitors, Hck activates PKCd via Tyr phosphorylation (Tyr311 and Tyr525), which in turn, activates PKCg via Ser and Thr phosphorylation (Thr514). The PKCd/PKCg complex also coprecipitates with lipid rafts in the membrane, presumably as a result of recruitment to this compartment through lysoPC priming [38] . LysoPCs also elicited coprecipitation of PKCg and activated PKCg with p47 phox , as well as a FRET + physical association (5 nm distance) of PKCg with p47
phox . Such data indicate that PKCg phosphorylates p47
phox as a result of these coprecipitations and the physical interactions between enzymes and substrates [12, 26] . Some of these data were confirmed using PKCg KO and WT mice, in which lysoPCs caused priming of WT PMNs but not PKCg KO PMNs, and in the PKCg KO murine PMNs, lysoPCs do not induce phosphorylation and translocation of p47
phox . Furthermore, lysoPCs caused coprecipitation of Hck with PKCd and PKCg, but the PKCd:PKCg complex was not observed in the PKCg KO PMNs. To determine if PKCg was responsible for lysoPC-mediated changes in PMN physiology in vivo, both WT and PKCg KO mice were used with a previously published rodent model for PMN-mediated ALI [19, 25] . In LPStreated mice, lysoPCs elicited ALI in the WT mice but did not cause ALI in PKCg KO mice, thereby indicating its relevance in the observed PMN priming and PMN-induced ALI in the setting of TRALI [19] . Importantly, PKCg KO mice contain normal levels of the other PKC isoenzymes, including PKCa, -b I , -b II , and -d, such that the observed lack of ALI could not be attributed to their absence [39, 40] .
Previous data have demonstrated that lysoPCs cause activation of PKC in mast cells, platelets, and endothelial cells, and the reported data are not surprising [41] [42] [43] [44] . Activation of PKCd is accomplished through Tyr phosphorylation, which has been linked to Src kinases and phosphorylation of Tyr311 with a second Tyr phosphorylation, which is variable [45] [46] [47] [48] [49] [50] . PKCd has been associated with assembly of the PMN oxidase, especially with the phosphorylation of p47 phox , and it contains an actinbinding domain, which may be associated with changes in actin polymerization, necessary for shape change and chemotaxis [51] [52] [53] [54] . Thus, activation of PKCd by Hck is plausible, as demonstrated by its physical association with PKCd in intact PMNs, pPKCd at Tyr311 and Tyr525 (the human equivalent of Tyr523 phosphorylation of rodent PKCd), the ability of active recombinant Hck to cause Tyr pPKCd, and the inhibition by tyrosine kinase inhibitors. Both PP2, a selective Src kinase inhibitor, and genistein, a Tyr-kinase antagonist, inhibited lysoPC priming, with the former decreasing pPKCd [35, 55] . Human pPKCd at Ser662, similar to Ser664 in the rodent PKCd, is likely a result of autophosphorylation [45, 56] . Conversely, PKCg was reported to be limited to the CNS and then was found in the lens of the eye, in epithelial cells, in HL-60 cells, a leukemia of granulocytic origin, and in rat PMNs [57] [58] [59] [60] [61] . In neurons, PKCg responds to rapid changes in cytosolic Ca 2+ , causes remodeling of the synaptic potential, has a role in longterm potentiation, and in some cases, is inhibitory [40, [62] [63] [64] [65] [66] [67] [68] . However, PKCg is not required for phorbol ester stimulation of neurons and has no role in the PMA-mediated changes in the long-term potentiation of the synaptic response, even though it is the dominant PKC isoform in neurons and is not depleted following long-term phorbol ester treatment of 3T3-F422A, unlike other cPKCs [67, 69] . Moreover, PKCg also responds to a rapid cytosolic Ca 2+ flux in neurons [66] . These data parallel lysoPC priming of PMNs, which causes rapid changes in cytosolic Ca 2+ , Hck activation, and stimulation of PKCd and PKCg [13] . phox membrane translocation, demonstrated by immunoreactivity for phosphoserine compared with albumin-treated control PMNs, as well as an increase of phosphoserine in the cytosol. (Bi) PMNs were analyzed via digital microscopy using fluorescently labeled antibodies to p47 phox (red), phosphoserine (blue), and lipid rafts (green). In albumin-treated PMNs, there is diffuse immunoreactivity for p47 Conversely, PMA activation of the respiratory burst does not require changes in cytosolic Ca 2+ and may occur when all cytosolic Ca 2+ is buffered by BAPTA-AM, as shown. Thus, the inability of PMA to cause translocation of PKCg is not unexpected from the data in neurons [40, [62] [63] [64] [65] [66] [67] [68] .
Insulin-like growth factor 1 causes activation of PKCd and PKCg in colonic epithelial cells, which are not interrelated, and lysoPCs to mediate their biologic effects through activation of PKC, although these data relied on PKC antagonists [42] [43] [44] 58] . In contrast, Ca 2+ chelation inhibited PKCg activation and membrane translocation but not PKCd. However, inhibition of PKCd activity by 2 different inhibitors, which do not affect PKCg at the concentrations used, decreased the translocation of PKCd and PKCg, indicating that PKCd activity is required for their interaction membrane translocation. In addition, although there is significant cross-talk and plasticity of PKC signaling between the cPKC and nPKC isoforms and complexes of these 2 distinct PKC isozymes, which translocate together in many cell lines, the direct activation of PKCg by PKCd has not been demonstrated [54, [70] [71] [72] [73] [74] . There is background PKC activity in the cytosol for many of the isoenzymes investigated, which may be a result of other distinct cellular processes. The focus of this manuscript was on the PKC isoenzymes that translocated to the membrane/lipid rafts and their activation through coprecipitation and FRET + physical interactions with specific substrates.
The coprecipitation of PKCd and PKCg with WAVE2 is not unexpected. WAVE2 and similar Wiskott-Aldrich proteins are scaffold proteins that regulate actin assembly in and promote polarized chemotaxis in PMNs [75] [76] [77] [78] [79] . LysoPCs are effective chemoattractants and rapidly cause changes in the PMN cytoskeleton and activate Hck, a Src family tyrosine kinase important for chemoattractant signaling and phosphorylation of SCAR (suppressor of cAMP receptor)/WAVE2 proteins [13, 16, 80, 81] . Moreover, the coprecipitation of PKCg and PKCd with lipid rafts elicited by lysoPCs is similar to that reported for FcgR activation of PMNs [38] .
In previous studies, lysoPC-mediated Hck activation was the direct result of the G bg subunit, and Hck-mediated activation of PKCd is novel [16] . The presence of PKCg in human PMNs, its activation by PKCd, and its requirement for lysoPC priming through phosphorylation and translocation of p47 phox are also novel. The identification of precise signaling pathways and specific proteins may lead to novel pharmacological inhibition of the described signaling, which could inhibit TRALI, in which lysoPCs have been implicated both in in vivo models and in humans [19, 22, 23, 82, 83] . AUTHORSHIP M.R.K. contributed to study design, performed most of the experiments, and primarily wrote the article. N.J.D.M. contributed to the microscopy design and experiments. A.B. contributed to study design. D.J.E. contributed to the study design and performed the experiments. F.G. contributed to the microscopy experiments and design. S.Y.K. contributed the microscopy experiments and the animal work. X.M. contributed to the study design and animal work. S.M. contributed to the RNA experiments and design. C.C.S. contributed to study design and writing of the article. Figure 10 . LysoPCs cause ALI in WT but not PKCg KO mice. WT and PKCg KO mice were treated with NS or LPS by intraperitoneal injection, 2 h before being transfused by tail vein with NS or lysoPCs, followed by EBD injection. ALI was measured as the percent of EBD leak into the lungs. WT mice (black bars) given LPS, followed by lysoPC infusion, had a significant increase in lung leak compared with the WT mice treated with NS and transfused with lysoPCs or NS and WT mice treated with LPS and infused with NS (P , 0.05). The PKCg KO mice (gray bars) did not have any significant lung leak in any group, including NS/NS, NS/lysoPC, and LPS/NS. Importantly, when the PKCg KO mice were treated with LPS and then infused with lysoPCs, there was no increased lung leak/ALI (*P , 0.05, each bar consists of 4 mice).
